German Bafin Started Wider Probe of Gerresheimer’s Reports

On March 6, Germany’s Bafin initiated an audit of the condensed interim consolidated financial statements and the accompanying interim management report of Gerresheimer as of May 31, 2025, according to a statement.

• Bafin has indication that the assessment of certain risks in the interim group management report for the period from Dec. 1, 2024, to May 31, 2025, in connection with the 2023/24 group management report was no longer accurate due to the financing of the acquisition of Bormioli Pharma
  • Recognition of impairment losses on assets was incorrectly omitted
  • Sales revenues and cost of sales in connection with bill-and-hold ...